NASDAQ:BIOA BioAge Labs Q3 2026 Earnings Results & Report $5.78 +0.09 (+1.49%) As of 02:17 PM Eastern This is a fair market value price provided by Massive. Learn more. BioAge Labs missed analyst earnings expectations in its Q3 2026 results, released November 5, 2026. The company reported EPS of -$0.73 versus the -$0.68 consensus estimate, while revenue was $298 thousand. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 5, 2026TimeAfter Market ClosesConference Call7:00 AM ET BioAge Labs EPS ResultsActual EPS-$0.73Consensus EPS -$0.68Beat/MissMissed by -$0.05One Year Ago EPSN/AEPS Beat Rate4 of last 6 quartersBioAge Labs Revenue ResultsActual Revenue$298 thousandExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) BioAge Labs Q3 2026 Earnings FAQ Did BioAge Labs beat earnings estimates for Q3 2026? BioAge Labs (NASDAQ:BIOA) reported earnings of -$0.73 per share for Q3 2026, missing the consensus estimate of -$0.68. The report was announced on Thursday, November 5, 2026. What was BioAge Labs' revenue for Q3 2026? BioAge Labs reported revenue of $298 thousand for Q3 2026. BioAge Labs Earnings HeadlinesBioAge Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 6, 2026 | marketscreener.comMBioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business UpdatesNovember 5, 2026 | globenewswire.comMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.November 10 at 1:00 AM | Porter & Company (Ad)Head-To-Head Contrast: InMed Pharmaceuticals (NASDAQ:INM) versus BioAge Labs (NASDAQ:BIOA)November 5, 2026 | americanbankingnews.comBioAge Labs, Inc. (NASDAQ:BIOA) Stock Has Average Price Target of $33.00 According to BrokeragesOctober 31, 2026 | americanbankingnews.comDeep Origin Announces Multi-Target Ai-Driven Drug Discovery Collaboration with BioAge Labs, IncOctober 14, 2026 | marketscreener.comMSee More BioAge Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like BioAge Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioAge Labs and other key companies, straight to your email. Email Address About BioAge LabsBioAge Labs (NASDAQ:BIOA) is a clinical-stage biotechnology company focused on developing medicines that target the biological mechanisms of aging. The company seeks to address diseases associated with aging by identifying therapeutic targets linked to human longevity and translating those discoveries into drug candidates. BioAge uses large human data sets, computational biology, and machine-learning tools to study the molecular factors that influence healthy aging and age-related disease. Its research has produced a pipeline of investigational therapies, including azelaprag (BGE-105), an apelin receptor agonist being evaluated for potential applications involving metabolic health, body composition, and physical function. Founded in 2015, BioAge is headquartered in Richmond, California, and conducts research and clinical development activities through collaborations and studies involving patients and research sites in multiple regions. The company is led by co-founder and Chief Executive Officer Kristen Fortney, Ph.D., whose background includes computational biology and aging research.View BioAge Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles DraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?Wall Street May Be Making a Big Mistake With monday.com StockCloudflare's 20% Sell-Off May Have Created an Opening for InvestorsMarketBeat Week in Review – 11/2 - 11/6 Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
